Hepatoprotective Potential of Apigenin versus Vitexin: A Comparative Study in an Acetaminophen-Induced Acute Liver Injury Rat's Model
DOI:
https://doi.org/10.31351/vol35iss1pp34-40Keywords:
Apigenin, vitexin, hepatoprotection, paracetamol, liver damageAbstract
Background: Paracetamol poisoning is a global issue that results in severe liver failure and permanent liver damage, necessitating the need for liver transplantation. The objective of our study was to assess and compare the preventive effects of Apigenin and vitexin against paracetamol-induced liver damage in rats.
Methods: Rats were divided into four groups and treated for seven consecutive days. Group I received 0.5% DMSO, Group II received a single paracetamol dose, and Groups III-IV received 10 mg/kg Apigenin or 40 mg/kg vitexin i.p for 7 days. On the seventh day, all groups except the Group I received a single oral dosage of 3000 mg/kg paracetamol three hours after their final Apigenin or vitexin dose. After 24 hours of paracetamol administration, the animals were sacrificed and their blood and livers were taken for biochemical and histopathological examination.
Results: The results demonstrated that paracetamol treatment led to notable increases (p < 0.05) in blood biochemical markers (ALT, AST, and ALP), in contrast to the negative control groups. However, after receiving Apigenin, rats exhibited a notable decrease (p<0.05) in the level of these biomarkers. After vitexin pretreatment, the levels of these enzymes were reduced, but this reduction was statistically significant only for the ALP level when compared to the paracetamol group. (p<0.05). Furthermore, Apigenin pretreatment was able to restore normal liver histopathology, while vitexin was not.
Conclusion: our research validated the hepatoprotective properties of Apigenin against paracetamol hepatotoxicity and provided insight into potential distinctions in the effects of a flavonoid and its glycosylated form.
How to Cite
Publication Dates
Received
Revised
Accepted
Published Online First
References
Hosack T, Damry D, Biswas S. Drug-induced liver injury: a comprehensive review. Therapeutic Advances in Gastroenterology. 2023 Mar;16:17562848231163410.
Cai X, Cai H, Wang J, Yang Q, Guan J, Deng J, Chen Z. Molecular pathogenesis of acetaminophen-induced liver injury and its treatment options. Journal of Zhejiang University-SCIENCE B. 2022 Apr;23(4):265-85.
Bernal W, Wendon J. Acute liver failure. New England Journal of Medicine. 2013 Dec 26;369(26):2525-34.
Teschke R, Danan G. Idiosyncratic drug induced liver injury, cytochrome P450, metabolic risk factors and lipophilicity: Highlights and controversies. International Journal of Molecular Sciences. 2021 Mar 26;22(7):3441.
Rotundo L, Pyrsopoulos N. Liver injury induced by paracetamol and challenges associated with intentional and unintentional use. World journal of hepatology. 2020 Apr 4;12(4):125.
Chang L, Xu D, Zhu J, Ge G, Kong X, Zhou Y. Herbal therapy for the treatment of acetaminophen-associated liver injury: recent advances and future perspectives. Frontiers in Pharmacology. 2020 Mar 11;11:313.
Tirmenstein MA, Nelson SD. Acetaminophen-induced oxidation of protein thiols. Contribution of impaired thiol-metabolizing enzymes and the breakdown of adenine nucleotides. Journal of Biological Chemistry. 1990 Feb 25;265(6):3059-65.
Jaeschke H, McGill MR, Ramachandran A. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug metabolism reviews. 2012 Feb 1;44(1):88-106.
Jaeschke H, Bajt ML. Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicological sciences. 2006 Jan 1;89(1):31-41.
Yan M, Huo Y, Yin S, Hu H. Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions. Redox Biol. 2018;17:274–83.
Millea PJ. N-acetylcysteine: multiple clinical applications. American family physician. 2009 Aug 1;80(3):265-9.
Whyte AJ, Kehrl T, Brooks DE, Katz KD, Sokolowski D. Safety and effectiveness of acetadote for acetaminophen toxicity. The Journal of emergency medicine. 2010 Nov 1;39(5):607-11.
Ali F, Rahul, Naz F, Jyoti S, Siddique YH. Health functionality of Apigenin: A review. International Journal of Food Properties. 2017 Jun 3;20(6):1197-238.
Salehi B, Venditti A, Sharifi-Rad M, Kręgiel D, Sharifi-Rad J, Durazzo A, Lucarini M, Santini A, Souto EB, Novellino E, Antolak H. The therapeutic potential of Apigenin. International journal of molecular sciences. 2019 Mar 15;20(6):1305.
He M, Min JW, Kong WL, He XH, Li JX, Peng BW. A review on the pharmacological effects of vitexin and isovitexin. Fitoterapia. 2016 Dec 1;115:74-85.
Duan S, Du X, Chen S, Liang J, Huang S, Hou S, Gao J, Ding P. Effect of vitexin on alleviating liver inflammation in a dextran sulfate sodium (DSS)-induced colitis model. Biomedicine & Pharmacotherapy. 2020 Jan 1;121:109683.
Noor KK, Ijaz MU, Ehsan N, Tahir A, Yeni DK, Zihad SN, Uddin SJ, Ashraf A, Simal-Gandara J. Hepatoprotective role of vitexin against cadmium-induced liver damage in male rats: A biochemical, inflammatory, apoptotic and histopathological investigation. Biomedicine & Pharmacotherapy. 2022 Jun 1;150:112934.
Prescott LF, Roscoe P, Wright N, Brown SS. Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. The Lancet. 1971 Mar 13;297(7698):519-22.
Henneh IT, Ahlidja W, Alake J, Kwabil A, Ahmed MA, Kyei-Asante B, Adinortey MB, Ekor M, Armah FA. Ziziphus abyssinica root bark extract ameliorates paracetamol-induced liver toxicity in rats possibly via the attenuation of oxidative stress. Toxicology Reports. 2022 Jan 1;9:1929-37.
Gowda S, Desai PB, Hull VV, Math AA, Vernekar SN, Kulkarni SS. A review on laboratory liver function tests. The Pan african medical journal. 2009 Nov 22;3:17.
Ahmed HM, Shehata HH, Mohamed GS, Abo-Gabal HH, El-Daly SM. Paracetamol overdose induces acute liver injury accompanied by oxidative stress and inflammation. Egyptian Journal of Chemistry. 2023 Mar 1;66(3):399-408.
Rašković A, Gigov S, Čapo I, Paut Kusturica M, Milijašević B, Kojić-Damjanov S, Martić N. Antioxidative and protective actions of Apigenin in a paracetamol-induced hepatotoxicity rat model. European Journal of Drug Metabolism and Pharmacokinetics. 2017 Oct;42:849-56.
Zhao L, Zhang J, Hu C, Wang T, Lu J, Wu C, Chen L, Jin M, Ji G, Cao Q, Jiang Y. Apigenin prevents acetaminophen-induced liver injury by activating the SIRT1 pathway. Frontiers in Pharmacology. 2020 Apr 24;11:514.
Hall P, Cash J. What is the real function of the liver ‘function’tests?. The Ulster medical journal. 2012 Jan;81(1):30.
Momenah MA, Ebrahim HA, Alzamil NM, Alfaifi M, Alshahrani MY, Kamar SS, Haidara MA, Al-Ani B, Dawood AF. Paracetamol Poisoning Induces Acute Liver Injury in Rats: Inhibition of miR-155/CD45 Axis-Mediated Anti-oxidant Depletion and Hepatotoxicity Using Quercetin and Resveratrol. International Journal of Morphology. 2022 Sep 1;40(5).
Kondža M, Bojić M, Tomić I, Maleš Ž, Rezić V, Ćavar I. Characterization of the CYP3A4 enzyme inhibition potential of selected flavonoids. Molecules. 2021 May 19;26(10):3018.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2026 Iraqi Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
